Please login to the form below

Not currently logged in
Email:
Password:

MRC

This page shows the latest MRC news and features for those working in and with pharma, biotech and healthcare.

Novartis gets EU nod for leukaemia drug Rydapt

Novartis gets EU nod for leukaemia drug Rydapt

or AML with myelodysplasia-related changes (AML-MRC) – while Celgene/Agios claimed approval for Idhifa (enasidenib) as a treatment for AML patients with the IDH2 mutation.

Latest news

More from news
Approximately 14 fully matching, plus 40 partially matching documents found.

Latest Intelligence

  • Pharma deals during July 2014 Pharma deals during July 2014

    As part of the collaborative spirit, the UK's Medical Research Council (MRC) announced this month that it has entered into an arrangement under which seven leading pharma companies (AZ, GSK, ... Based on a similar concept to the AZ-MRC initiative

  • Pharma deals during March 2014 Pharma deals during March 2014

    Under the five-year agreement, scientists from the MRC will work closely with AZ's scientists to identify drug targets and screen promising candidates. ... If this option is not used, MRC scientists will be free to negotiate with other parties.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

More from appointments
Approximately 2 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Rainmaker Healthcare Communications

Rainmaker is an independent, award-winning communications agency with offices in London and Atlanta. Our experience across pharmaceuticals, generics, OTC, medical...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics